C57 - Developing the Treatments of Tomorrow II: Clinical Trials in Neurology

Event Time: Sunday April 22, 2018 3:30 pm to 5:30 pm
Topic(s): Research Methodology, Education, and History
Director(s): Jeffrey Gelfand MD, MAS, FAAN
Description: This program will provide an overview and update of the science of clinical trials for practicing neurologists, researchers, and trainees. Clinical trials are the bedrock of evidence-based neurology and one of the most important methodological innovations of modern medicine. Faculty from academia, industry, and government will provide an overview of clinical trials, discuss approaches to optimize success, review advances in trial design and implementation, address statistical and regulatory considerations, and facilitate a discussion with attendees. A companion session will address the preclinical drug development pipeline, translation of research breakthroughs to the clinic, and first-in-human studies. This program complements C43: Developing the Treatments of Tomorrow I: Taking Molecules from Lab to Man, but covers independent topics.
Completion Message: Participants should be able to understand differences between early- and late-stage clinical trials and their role in the drug development pipeline, assess the strengths and weaknesses of various clinical trial designs, apply appropriate statistical approaches, and understand regulatory issues.
CME Credits: 2
Core Competencies: Patient Care, Professionalism, Systems-Based Practice, Medical Knowledge

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses